Book Shorter, Edward; (2009)
Before Prozac: The Troubled History of Mood Disorders in Psychiatry (/isis/citation/CBB000952059/)

Book Daemmrich, Arthur; Radin, Joanna; (2007)
Perspectives on Risk and Regulation: The FDA at 100 (/isis/citation/CBB000930536/)

Book Mikkael A. Sekeres; (2022)
Drugs and the FDA: Safety, Efficacy, and the Public's Trust (/isis/citation/CBB614307145/)

Article Tyabji, Nasir; (2012)
Negotiating Nonalignment: Dilemmas Attendant on Initiating Pharmaceutical Production in India (/isis/citation/CBB001230795/)

Book Graham Dutfield; (2020)
That high design of purest gold : A critical history of the pharmaceutical industry, 1880-2020 (/isis/citation/CBB895555531/)

Article Tobbell, Dominique A.; (2008)
Allied against Reform: Pharmaceutical Industry--Academic Physician Relations in the United States, 1945--1970 (/isis/citation/CBB000930716/)

Article Timmermans, Stefan; Leiter, Valerie; (2000)
The redemption of Thalidomide: Standardizing the risk of birth defects (/isis/citation/CBB000110296/)

Article Daemmrich, Arthur; (2007)
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation. (/isis/citation/CBB000932013/)

Book Quirke, Viviane; Slinn, Judy; (2009)
Perspectives on Twentieth-Century Pharmaceuticals (/isis/citation/CBB001022688/)

Book Hilts, Peter J.; (2003)
Protecting America's Health: The FDA, Business, and One Hundred Years of Regulation (/isis/citation/CBB000502240/)

Article Giulia Bovone; (2023)
Non solo talidomide: Tetracicline, Fenmetrazina e Aminofillina. L’altra faccia delle malformazioni fetali negli anni Cinquanta (/isis/citation/CBB331834173/)

Article Simon, Jonathan; (2007)
The Origin of the Production of Diphtheria Antitoxin in France, between Philanthropy and Commerce (/isis/citation/CBB000820146/)

Article Nik-Khah, Edward; (2014)
Neoliberal Pharmaceutical Science and the Chicago School of Economics (/isis/citation/CBB001421181/)

Article Gaudillière, Jean-Paul; Thoms, Ulrike; (2013)
Pharmaceutical Firms and the Construction of Drug Markets: From Branding to Scientific Marketing (/isis/citation/CBB001320751/)

Book Carpenter, Daniel; (2010)
Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA (/isis/citation/CBB001020607/)

Article Quirke, Viviane; (2009)
The Material Culture of British Pharmaceutical Laboratories in the Golden Age of Drug Discovery (c. 1935--75) (/isis/citation/CBB001231642/)

Article Thoms, Ulrike; (2013)
Standardizing Selling. Pharmaceutical Marketing, the Pharmaceutical Company and the Marketing Expert (1900--1980) (/isis/citation/CBB001320755/)

Article Greene, Jeremy A.; (2011)
What's in a Name? Generics and the Persistence of the Pharmaceutical Brand in American Medicine (/isis/citation/CBB001230383/)

Article Kauffman, George B.; Mayo, Isaac; Craig, G. Wayne; (2006)
LSD: Albert Hofmann's “Problem Child” (/isis/citation/CBB001252558/)

Article Daemmrich, Arthur; (2002)
A Tale of Two Experts: Thalidomide and Political Engagement in the United States and West Germany (/isis/citation/CBB000200026/)